mAbxience

mAbxience

Switzerland - Lugano
Biotechnology
WebsiteLinkedInCareers Page

Focus: Biosimilar Monoclonal antibodies

mAbxience is a life sciences company focused on Biosimilar Monoclonal antibodies.

OncologyImmunology
Funding Stage
PRIVATE
Employees
51-200
Open Jobs
0

Pipeline & Clinical Trials

Phase 1
Clinical Trials (1)
NCT04238650A Pharmacokinetic Study Comparing MB02 And EU Avastin® In Healthy Male Volunteers
Phase 1
Phase 1
Clinical Trials (1)
NCT03293654A Pharmacokinetic Study Comparing MB02 And US And EU Avastin® In Healthy Male Volunteers
Phase 1
Phase 1
Clinical Trials (1)
NCT05121246A PK Study Comparing MB05, EU-sourced Synagis® and US-sourced Synagis® in Healthy Volunteers.
Phase 1
Phase 1
Clinical Trials (1)
NCT05299073A Study Comparing the Pharmacokinetic Similarity of MB09 and EU/US-Sourced Xgeva
Phase 1
Phase 1
Clinical Trials (1)
NCT04540627Exploratory Study to Estimate the Prophylactic Efficacy of Palivizumab in Healthy Adult Participants Inoculated With RSV
Phase 1
Phase 1
Clinical Trials (1)
NCT04408989A Study Comparing the Pharmacokinetic Similarity of MB02-SP, MB02-DM and US Licensed-Avastin®.
Phase 1
Phase 1
Clinical Trials (1)
NCT06392074A Study Investigating the Safety, Absorption, and Elimination of MB04, a New Compound That May Potentially be Used in the Treatment of Autoimmune Disorders
Phase 1
Phase 1
Clinical Trials (1)
NCT02069704Bioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN®) in First-line Treatment mCRC Patients
Phase 1
Phase 1
Clinical Trials (1)
NCT04238663Pharmacokinetic Study Comparing MB02 And US And EU Avastin® In Healthy Male Volunteers
Phase 1
Phase 3
Clinical Trials (1)
NCT02268045Study of RTXM83 Plus CHOP Chemotherapy Versus a Rituximab Plus CHOP Therapy in Patients With Non Hodgkin's Lymphoma
Phase 3
Phase 3
Clinical Trials (1)
NCT07221734Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] Melanoma
Phase 3
Phase 3
Clinical Trials (1)
NCT05338086A Study to Compare Efficacy, PK, PD, Safety and IMM of MB09 to Prolia® [EU-sourced] in Postmenopausal Osteoporosis.
Phase 3
Phase 3
Clinical Trials (1)
NCT06596772A Study to Compare Efficacy, Pharmacokinetics, Safety and Immunogenicity of MB04 [proposed Etanercept Biosimilar] to Enbrel® [EU-sourced] in Rheumatoid Arthritis
Phase 3
Phase 3
Clinical Trials (1)
NCT03296163A Study Comparing MB02 and Avastin® in Subjects With Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Phase 3
Clinical Trials (1)
NCT06687369A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in Non-small Cell Lung Cancer (BENITO Study)
Phase 3

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 15 clinical trials